Literature DB >> 6480072

Lymphocyte sub-populations and NSAIDs. Methodological aspects.

P A Bacon, M Salmon, A Blann, D G Scott, M Farr.   

Abstract

Activated lymphocytes can be enumerated as the less dense lymphocyte population (LDL) on a Ficoll density gradient column. The numbers of LDL are higher in rheumatoid arthritis (RA) but fall with successful second-line therapy; they correlate with active synovitis rather than with extra-articular disease. A cytospin technique has been developed which uses fewer cells than conventional suspension techniques and which allows further characterization of LDL using monoclonal antibodies. This confirms that these cells are relatively T-depleted but enriched in IA bearing cells, which may relate to homing patterns to the RA synovium. Using this technique, RA patients with active synovitis were shown to have more LDL and IA bearing cells, as were the active disease controls, including patients with other autoimmune disease (vasculitis) and with non-immune disease (sepsis). There were no differences between the ratios of T-suppressor to T-helper cells within these patient groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480072     DOI: 10.1007/bf00915715

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Selective migration of lymphocytes within the mouse small intestine.

Authors:  D M Parrott; A Ferguson
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

Review 2.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

4.  Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents.

Authors:  E M Veys; P Hermanns; G Goldstein; P Kung; J Schindler; J Van Wauwe
Journal:  Int J Immunopharmacol       Date:  1981

5.  Lymphapheresis in rheumatoid arthritis. A randomized trial.

Authors:  J Karsh; J H Klippel; P H Plotz; J L Decker; D G Wright; M W Flye
Journal:  Arthritis Rheum       Date:  1981-07

6.  Circulating activated lymphocytes in rheumatoid arthritis: a marker of synovial inflammation.

Authors:  G M Papadimitriou; P A Bacon; N D Hall
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

7.  In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies.

Authors:  C J Meijer; C B de Graaff-Reitsma; G J Lafeber; A Cats
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

8.  Low density lymphocytes: their relationship to disease activity and to antirheumatic therapy.

Authors:  G J Alexander; P A Bacon; F Cavalcanti; D R Blake; N D Hall
Journal:  Br J Rheumatol       Date:  1984-02

9.  Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.

Authors:  J M Depper; H G Bluestein; N J Zvaifler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis.

Authors:  E M Veys; P Hermanns; G Verbruggen; J Schindler; G Goldstein
Journal:  J Rheumatol       Date:  1982 Nov-Dec       Impact factor: 4.666

View more
  1 in total

1.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.